Pradžia › Prostatos vėžys › Tennessee
Prostatos vėžys klinikiniai tyrimai Tennessee
49 tyrimai dėl Prostatos vėžys ieško dalyvių vietose Tennessee.
Miestai Tennessee
Oficialus tyrimo tekstas (anglų kalba)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Sarah Cannon Research Institute, Nashville
Renkami dalyviai1/2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Tennessee Oncology PLLC, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06465069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- SCRI Oncology Partners, Nashville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Vanderbilt University/Ingram Cancer Center, Nashville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Tennessee Oncology, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-28 · NCT06095089DESTINY-PANTUMOUR04
- Research Site, Nashville
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07124000A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- The Conrad Pearson Clinic, Germantown
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-25 · NCT07832292Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Sarah Cannon Research Institute, Nashville
- Urology Associates, Nashville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-25 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- The West Clinic, PLLC dba West Cancer Center ( Site 0063), Germantown
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Tennessee Oncology, PLLC - Chattanooga Downtown, Chattanooga
- Tennessee Oncology PLLC, Chattanooga
- Tennessee Oncology, PLLC - Chattanooga Med Park II, Chattanooga
- ir dar 20
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-24 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- Tennessee Oncology, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-24 · NCT07719361A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Sarah Cannon Research Institute Oncology Partners, Nashville
- United States Oncology Regulatory Affairs Corporate Office, Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-22 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Tennessee Oncology PLLC, Chattanooga
Renkami dalyviai3 fazė
Amžius nuo 18 iki 100 · Vyrams · Atnaujinta 2026-09-22 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-18 · NCT06952803A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Nashville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-18 · NCT06990880High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Memphis VA Medical Center, Memphis, TN, Memphis
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-17 · NCT05011383Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
- Sarah Cannon Research Institute, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-17 · NCT07813637A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Memphis VA Medical Center ( Site 0072), Memphis
- SCRI Oncology Partners ( Site 0074), Nashville
- Henry-Joyce Cancer Clinic ( Site 0042), Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-17 · NCT06925737Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Sarah Cannon Research Institute Oncology Partners, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-15 · NCT07493512Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Urology Associates of Nashville, Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-11 · NCT06056830A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Sarah Cannon Research Center, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06440005A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Sarah Cannon Research Institute, Nashville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-04 · NCT07567846Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- SCRI Oncology Partners, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-03 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Tennessee Oncology Nashville, Nashville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-03 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-26 · NCT07611110Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Sarah Cannon Research Institute, Nashville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-24 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- United States Oncology Regulatory Affairs Corporate Office, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-21 · NCT04221542A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Henry-Joyce Cancer Clinic, Nashville
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-08-17 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Sarah Cannon Research, Nashville
Renkami dalyviai1 fazė
Amžius nuo 18 iki 100 · Vyrams · Atnaujinta 2026-08-13 · NCT05519449Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
- Tennessee Oncology PLLC, Nashville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-30 · NCT07288359Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #102, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-23 · NCT06545942PSMA PET Combined With MRI for the Detection of PCa
- The Conrad Pearson Clinic, Germantown
- Urology Associates of Nashville, Nashville
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-07-23 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Vanderbilt University/Ingram Cancer Center, Nashville
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-07-14 · NCT06592924Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- Sarah Cannon Research Institute, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-07-02 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Memphis VA Medical Center, Memphis
- Baptist Clinical Research Institute, Memphis
Renkami dalyviaiStebimasis tyrimas
Amžius 21 ir vyresni · Vyrams · Atnaujinta 2026-05-22 · NCT03151629Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sarah Cannon Research Institute, Nashville
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-06 · NCT06239194A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
- Vanderbilt University Medical Center, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-13 · NCT06778863A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Urology Associates PC, Nashville
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-02-04 · NCT04729114Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- The West Clinic - Wolf River, Germantown
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-01-22 · NCT06470243Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.